Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

200 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers.
Romanska HM, Potemski P, Krakowska M, Mieszkowska M, Chaudhri S, Kordek R, Kubiak R, Speirs V, Hanby AM, Sadej R, Berditchevski F. Romanska HM, et al. Among authors: speirs v. Br J Cancer. 2015 Nov 3;113(9):1350-7. doi: 10.1038/bjc.2015.344. Epub 2015 Sep 29. Br J Cancer. 2015. PMID: 26418423 Free PMC article.
PSMD9 expression predicts radiotherapy response in breast cancer.
Langlands FE, Dodwell D, Hanby AM, Horgan K, Millican-Slater RA, Speirs V, Verghese ET, Smith L, Hughes TA. Langlands FE, et al. Among authors: speirs v. Mol Cancer. 2014 Mar 28;13:73. doi: 10.1186/1476-4598-13-73. Mol Cancer. 2014. PMID: 24673853 Free PMC article.
Breast cancer: Investment biobanking--increased returns from tissue samples.
Speirs V, Morgan A. Speirs V, et al. Nat Rev Clin Oncol. 2013 Mar;10(3):128-9. doi: 10.1038/nrclinonc.2013.19. Epub 2013 Feb 5. Nat Rev Clin Oncol. 2013. PMID: 23381001 No abstract available.
Role of ERβ in Clinical Breast Cancer.
Speirs V, Shaaban AM. Speirs V, et al. Cancer Treat Res. 2009;147:1-20. doi: 10.1007/978-0-387-09463-2_2. Cancer Treat Res. 2009. PMID: 21461830 No abstract available.
Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma.
Kamal M, Shaaban AM, Zhang L, Walker C, Gray S, Thakker N, Toomes C, Speirs V, Bell SM. Kamal M, et al. Among authors: speirs v. Breast Cancer Res Treat. 2010 Jun;121(3):555-63. doi: 10.1007/s10549-009-0500-4. Epub 2009 Aug 8. Breast Cancer Res Treat. 2010. PMID: 19669408
Hormone receptors in defining breast cancer prognosis--time for a rethink?
Speirs V, Shaaban AM. Speirs V, et al. Nat Clin Pract Oncol. 2007 Apr;4(4):204-5. doi: 10.1038/ncponc0771. Nat Clin Pract Oncol. 2007. PMID: 17392711 No abstract available.
A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERbeta in archival formalin-fixed paraffin embedded human breast tissue.
Carder PJ, Murphy CE, Dervan P, Kennedy M, McCann A, Saunders PT, Shaaban AM, Foster CS, Witton CJ, Bartlett JM, Walker RA, Speirs V. Carder PJ, et al. Among authors: speirs v. Breast Cancer Res Treat. 2005 Aug;92(3):287-93. doi: 10.1007/s10549-004-4262-8. Breast Cancer Res Treat. 2005. PMID: 16155800 Clinical Trial.
200 results
Jump to page
Feedback